Data Collaborative on Health Systems Performance
The Health Systems Innovation Lab, in partnership with Microsoft, Accenture, and the Novartis Foundation, launched the Data Collaborative on Health Systems Performance (DC-HSP), an initiative that aims to harness unexplored health data to assess system performance, especially concerning cardiovascular diseases, to guide policies and innovations. The DC-HSP's two-phase approach involves data compilation, advanced research methods, and translating findings into actionable policy recommendations.
Transitioning to High-Value Health Systems in G20+ Countries
The report highlights G20+ nations' challenges with rising healthcare costs and disparities. Their goal is efficient, equitable, and effective healthcare. Despite efforts, no major population-level impact is seen. Harvard's HSIL introduces a 10-component High-Value Health System Model. While countries have adopted parts of this model, none have fully realized it.
The Health Systems and Cancer Initiative in Latin America
The Health Systems and Cancer Initiative in Latin America (HSCI-LA) is a collaborative effort involving several Latin American countries to address the growing cancer burden. It seeks to understand each country's health system challenges, suggests policy options, and fosters a learning network for stakeholders to share experiences and innovate solutions for cancer care.
The Global Health and Population Project on Access to Care for Cardiometabolic Diseases
The Global Health and Population Project on Access to Care for Cardiometabolic Diseases (HPACC) is an international consortium aimed at addressing cardiometabolic disease concerns globally. It collects and harmonizes data, especially from low- and middle-income countries, aiming to fill research gaps and become a leading center for data sharing and analysis.
Global Health Policy Lab
The "Global Health Policy Lab" (GHPL) is a collaboration between Harvard Health Systems Innovation Lab and the Charité Center for Global Health. Aiming to bolster global health via digital tools, it seeks to digitalize health laws and policies, aligning with WHO's Digital Health Strategy. By bridging science and policy, GHPL, backed by the Virchow Foundation and partnered with the World Health Summit, targets improved global health outcomes.
Strategic Public Private Partnerships
Novartis, Novo Nordisk, and the Health Systems Innovation Lab introduced a partnership initiative to combat cardiovascular disease. These Strategic Public-Private Partnerships aim for long-term collaboration, focusing on trust and value creation in health systems. Such partnerships enhance health system efficiency and equity, ensuring broad, equitable access to health solutions and addressing societal needs.
The Health Systems Innovation Lab conducts studies on innovative financing for health services, guiding organizations and governments to develop sustainable mechanisms. Focus areas include surgery, cardiovascular disease, cancer, HIV/AIDS, and Malaria.
The Global Collaborative for Changing Diabetes in Children
The Health Systems Innovation Lab collaborates with Changing Diabetes in Children, a partnership between Novo Nordisk and 14 countries in Africa and Asia, to enhance T1D services for young patients. The GC-CDIC program focuses on four areas: Digital Data systems, Research, Innovation Lab, and Translation Hub.
Digital Health Systems
Digital technologies deeply influence various aspects of our lives, but health systems have been slow to harness their full potential. DHS collaboration, comprising international stakeholders from multiple sectors, aims to promote value-based digital transformations in healthcare to enhance patient health outcomes globally.
The Health System Innovation Lab (HSIL) Hackathon is a transformative event with a clear mission: to empower innovators to create solutions that enhance healthcare systems globally.
Venture Incubation Program
The Venture Incubation Program is a remote six-month program designed to provide continuity following the Annual HSIL Hackathon and grow early-stage ventures poised to contribute substantially to health system innovation through digital health solutions to tackle cancer and cardiovascular diseases.